Literature DB >> 15114683

Peripheral CD4loCD40+ auto-aggressive T cell expansion during insulin-dependent diabetes mellitus.

Dan M Waid1, Gisela M Vaitaitis, David H Wagner.   

Abstract

The generation of auto-aggressive T cells involves failure of central or peripheral tolerance. We previously demonstrated that peripheral CD4(lo)CD40(+) T cells give rise to pathogenic T cells in the non-obese diabetic (NOD) model. Here we show that peripheral CD4(+)CD40(+) T cells from diabetic or pre-diabetic NOD mice induce insulin-dependent diabetes mellitus. Consistent with breach of peripheral tolerance, CD4(lo)CD40(+) T cells expand with age in NOD mice but not in MHC-matched non-obese resistant (NOR) or BALB/c controls. Suggestive of a causal role for CD40 in autoimmunity, blocking CD40-CD154 interactions early during NOD development prevents autoaggressive T cell expansion while promoting increases in CD4(+)CD25(+) regulatory T cells. Importantly, CD40 signals promote expansion of V alpha 3.2(+) and V alpha 8.3(+) T cells. Furthermore, peripheral V alpha 3.2(+)CD40(+) T cells induce diabetes in NOD.scid recipients while V alpha 8.3(+) T cells or V alpha 3.2(+)-depleted T cell populations do not. This is the first demonstration that primary T cells transfer disease with the kinetics of auto-aggressive T cell clones and that specific TCR V alpha expansion promotes diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114683     DOI: 10.1002/eji.200324703

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

1.  CD40 glycoforms and TNF-receptors 1 and 2 in the formation of CD40 receptor(s) in autoimmunity.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Mol Immunol       Date:  2010-06-19       Impact factor: 4.407

2.  The co-evolution of our understanding of CD40 and inflammation.

Authors:  D H Wagner
Journal:  Diabetologia       Date:  2009-04-10       Impact factor: 10.122

3.  Induction of recombinase activity in peripheral T cells in multiple sclerosis.

Authors:  E M Kuklina; I V Nekrasova; O L Schuklina; T V Baydina; I Yu Danchenko
Journal:  Dokl Biol Sci       Date:  2014-01-03

Review 4.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

5.  Activation of antigen receptor genes rearrangement in peripheral blood T lymphocytes as a possible mechanism of autoimmunity induction.

Authors:  E M Kuklina; V A Lopatina; O L Gorbunova; E N Smirnova; K S Shtain; O L Shchuklina; V P Timganova
Journal:  Dokl Biol Sci       Date:  2011-01-09

6.  A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.

Authors:  Gisela M Vaitaitis; Martin G Yussman; David H Wagner
Journal:  J Neuroimmunol       Date:  2019-03-21       Impact factor: 3.478

Review 7.  CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes.

Authors:  Kathryn Haskins; Anne Cooke
Journal:  Curr Opin Immunol       Date:  2011-09-12       Impact factor: 7.486

Review 8.  T-cell receptor revision: friend or foe?

Authors:  J Scott Hale; Pamela J Fink
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

9.  An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Authors:  Gisela M Vaitaitis; Jessica R Carter; Dan M Waid; Michael H Olmstead; David H Wagner
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

10.  Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation.

Authors:  Guiying Deng; Jessica Carter; Richard J Traystman; David H Wagner; Paco S Herson
Journal:  J Neuroimmunol       Date:  2014-07-22       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.